Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C

NCT00227435 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: val-mCyd

Sponsor

Merck Sharp & Dohme LLC